SUN PHARMACEUTICAL IND L vs Zenotech Laboratories Ltd

A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and Zenotech Laboratories Ltd (ZENOTECHLABORATORIESLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs ZENOTECHLABORATORIESLTD on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth20
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

40.39
P/E ratio
0.00
20.07
P/B ratio
2.89
0.84%
Dividend yield
0.00%
₹47.84
EPS
₹0.92

Profitability

SUNPHARMA takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.00%
Return on equity
-1.17%
21.00%
Return on capital
9.40%
30.00%
EBITDA margin
32.94%
19.69%
Net margin
13.03%

Growth

SUNPHARMA takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
-2.30%
10.57%
Profit CAGR (3Y)
-31.66%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.63L Cr
Market cap
₹278 Cr
₹58,462 Cr
Revenue
₹43 Cr
₹11,509 Cr
Net profit
₹6 Cr
0.61
Debt / equity
0.00
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Zenotech Laboratories Ltd
  • + ["Company is almost debt free."]
  • ["Stock is trading at 3.01 times its book value", "Company has a low return on equity of 4.25% over last 3 years.", "Debtor days have increased from 55.2 to 73.5 days."]
SUN PHARMACEUTICAL IND L full analysis Zenotech Laboratories Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.